118 related articles for article (PubMed ID: 20349754)
1. Assessment of long term status of sputum positive pulmonary TB patients successfully treated with short course chemotherapy.
Banu Rekha VV; Ramachandran R; Kuppu Rao KV; Rahman F; Adhilakshmi AR; Kalaiselvi D; Murugesan P; Sundaram V; Narayanan PR
Indian J Tuberc; 2009 Jul; 56(3):132-40. PubMed ID: 20349754
[TBL] [Abstract][Full Text] [Related]
2. Post treatment sequelae of multi-drug resistant tuberculosis patients.
Singla N; Singla R; Fernandes S; Behera D
Indian J Tuberc; 2009 Oct; 56(4):206-12. PubMed ID: 20469732
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting.
Maguire GP; Anstey NM; Ardian M; Waramori G; Tjitra E; Kenangalem E; Handojo T; Kelly PM
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1500-6. PubMed ID: 19919767
[TBL] [Abstract][Full Text] [Related]
5. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
[TBL] [Abstract][Full Text] [Related]
6. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
Kameda K; Kawabata S; Masuda N
Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
[TBL] [Abstract][Full Text] [Related]
7. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
[TBL] [Abstract][Full Text] [Related]
10. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
[TBL] [Abstract][Full Text] [Related]
11. Frequency of isolated positive sputum cultures among pulmonary tuberculosis patients.
Al-Hakeem MM; Chaudhary AR; Aziz S; Al-Aska AK
Saudi Med J; 2005 Apr; 26(4):634-40. PubMed ID: 15900375
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis control in Bangladesh: success of the DOTS strategy.
Kumaresan JA; Ahsan Ali AK; Parkkali LM
Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115
[TBL] [Abstract][Full Text] [Related]
13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
14. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis.
Colebunders R; Bastian I
Int J Tuberc Lung Dis; 2000 Feb; 4(2):97-107. PubMed ID: 10694086
[TBL] [Abstract][Full Text] [Related]
15. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
Xu WG; Gao Z; Fan BD
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands.
Geerligs WA; Van Altena R; De Lange WCM ; Van Soolingen D; Van Der Werf TS
Int J Tuberc Lung Dis; 2000 Aug; 4(8):758-64. PubMed ID: 10949328
[TBL] [Abstract][Full Text] [Related]
17. Retrospective descriptive study of adult tuberculosis in Wuhan, China.
Chamla DD; Nie S; Duan Q
Int J Tuberc Lung Dis; 2004 Jun; 8(6):730-6. PubMed ID: 15182143
[TBL] [Abstract][Full Text] [Related]
18. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
Kwange SO; Budambula NL
Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
[TBL] [Abstract][Full Text] [Related]
20. Smoking prolongs the infectivity of patients with tuberculosis.
Siddiqui UA; O'Toole M; Kabir Z; Qureshi S; Gibbons N; Kane M; Keane J
Ir Med J; 2010 Oct; 103(9):278-80. PubMed ID: 21186753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
